Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles

Abstract

Most GISTs require oncogenic activation of the KIT or PDGFRA receptor tyrosine kinase proteins, and the genomic mechanisms of oncogene activation are heterogeneous. Notably, the kinase mutation type correlates with both tumor biology and imatinib response. For example, GISTs with KIT exon 11 mutations are typically gastric and have excellent imatinib response, whereas those with KIT exon 9 mutations generally arise in the small bowel and are less responsive to imatinib. To identify genes that might contribute to these biological differences, we carried out gene expression profiling of 26 GISTs with known KIT and PDGFRA mutational status. Expression differences were then evaluated further by RNA in situ hybridization, immunohistochemistry, and immunoblotting. Unsupervised hierarchical clustering grouped tumors with similar mutations together, but the distinction between the different groups was not absolute. Differentially expressed genes included ezrin, p70S6K, and PKCs, which are known to have key roles in KIT or PDGFRA signaling, and which might therefore contribute to the distinctive clinicopathological features in GISTs with different mutation types. These gene products could serve as highly selective therapeutic targets in GISTs containing the KIT or PDGFRA mutational types with which they are associated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, DeMatteo RP and Besmer P . (2003). Clin. Cancer Res., 9, 3329–3337.

  • Antonescu CR, Viale A, Sarran L, Tschernyavsky SJ, Gonen M, Segal NH, Maki RG, Socci ND, DeMatteo RP and Besmer P . (2004). Clin. Cancer Res., 10, 3282–3290.

  • Besmer P . (1991). Curr. Opin. Cell Biol., 3, 939–946.

  • Besmer P . (1997). Mol. Cell Biol. 2nd edn Marcel Dekker: New York, pp. 369–404.

    Google Scholar 

  • Blume-Jensen P, Ronnstrand L, Gout I, Waterfield MD and Heldin CH . (1994). J. Biol. Chem., 269, 21793–21802.

  • Brazil DP, Park J and Hemmings BA . (2002). Cell, 111, 293–303.

  • Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M and Bridge JA . (2000). Cancer Genet. Cytogenet., 120, 111–116.

  • Bretscher A, Edwards K and Fehon RG . (2002). Nat. Rev. Mol. Cell. Biol., 3, 586–599.

  • Cantley LC . (2002). Science, 296, 1655–1657.

  • Corless CL, McGreevey L, Haley A, Town A and Heinrich MC . (2002). Am. J. Pathol., 160, 1567–1572.

  • Debiec-Rychter M, Dumez H, Judson I, Wasag B, Verweij J, Brown M, Dimitrijevic S, Sciot R, Stul M, Vranck H, Scurr M, Hagemeijer A, van Glabbeke M, van Oosterom AT and EORTC Soft Tissue and Bone Sarcoma Group. (2004a). Eur. J. Cancer, 40, 689–695.

  • Debiec-Rychter M, Wasag B, Stul M, De Wever I, Van Oosterom A, Hagemeijer A and Sciot R . (2004b). J. Pathol., 202, 430–438.

  • Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C Fletcher CD and Joensuu H . (2002). N. Engl. J. Med., 347, 472–480.

  • Duensing A, Medeiros F, McConarty B, Joseph NE, Panigrahy D, Singer S, Fletcher CD, Demetri GD and Fletcher JA . (2004). Oncogene, 23, 3999–4006.

  • Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci., USA., 95, 14863–14868.

  • Frodin M and Gammeltoft S . (1999). Mol. Cell. Endocrinol., 151, 65–77.

  • Gunawan B, Schulten HJ, von Heydebreck A, Schmidt B, Enders C, Hoer J, Langer C, Schuler P, Schindler CG, Kuhlgatz J and Fuzesi L . (2004). J. Pathol., 202, 421–429.

  • Hahn WC and Weinberg RA . (2002). Nat. Rev. Cancer, 2, 331–341.

  • Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S and Fletcher JA . (2003b). J. Clin. Oncol., 21, 4342–4349.

  • Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD and Fletcher JA . (2003a). Science, 299, 708–710.

  • Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y and Kitamura Y . (1998). Science, 279, 577–580.

  • Hirota S, Nishida T, Isozaki K, Taniguchi M, Nakamura J, Okazaki T and Kitamura Y . (2001). J. Pathol., 193, 505–510.

  • Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y and Kitamura Y . (2003). Gastroenterology, 125, 660–667.

  • Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ . (2004). Nat. Med., 10, 182–186.

  • Kinoshita K, Isozaki K, Hirota S, Nishida T, Chen H, Nakahara M, Nagasawa Y, Ohashi A, Shinomura Y, Kitamura Y and Matsuzawa Y . (2003). J. Gastroenterol. Hepatol., 18, 147–151.

  • Kohno T, Takakura S, Yamada T, Okamoto A, Tanaka T and Yokota J . (1999). Cancer Res., 59, 4170–4174.

  • Koon N, Schneider-Stock R, Sarlomo-Rikala M, Lasota J, Smolkin M, Petroni G, Zaika A, Boltze C, Meyer F, Andersson L, Knuutila S, Miettinen M and El-Rifai W . (2004). Gut., 53, 235–240.

  • Linn SC, West RB, Pollack JR, Zhu S, Hernandez-Boussard T, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Siegmund D, Botstein D, Brown PO, Gilks CB and van de Rijn M . (2003). Am. J. Pathol., 163, 2383–2395.

  • Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB and van de Rijn M . (2002). Am. J. Pathol., 161, 1557–1565.

  • Louvet-Vallee S . (2000). Biol. Cell., 92, 305–316.

  • Lux ML, Rubin BP, Biase TL, Chen CJ, Maclure T, Demetri G, Xiao S, Singer S, Fletcher CD and Fletcher JA . (2000). Am. J. Pathol., 156, 791–795.

  • Nakahara M, Isozaki K, Hirota S, Miyagawa J, Hase-Sawada N, Taniguchi M, Nishida T, Kanayama S, Kitamura Y, Shinomura Y and Matsuzawa Y . (1998). Gastroenterology, 115, 1090–1095.

  • Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D and van de Rijn M . (2002). Lancet, 359, 1301–1307.

  • Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D . (2000). Nature, 406, 747–752.

  • Plo I, Lautier D, Casteran N, Dubreuil P, Arock M and Laurent G . (2001). Oncogene, 20, 6752–6763.

  • Porter AC and Vaillancourt RR . (1998). Oncogene, 17, 1343–1352.

  • Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, Demetri GD, Fletcher CD and Fletcher JA . (2001). Cancer Res., 61, 8118–8121.

  • Sanders KM, Ordog T, Koh SD, Torihashi S and Ward SM . (1999). Neurogastroenterol. Motil., 11, 311–338.

  • Sato S, Fujita N and Tsuruo T . (2000). Proc. Natl. Acad. Sci. USA, 97, 10832–10837.

  • Schonthal AH . (2001). Cancer Lett., 170, 1–13.

  • Silverstein AM, Barrow CA, Davis AJ and Mumby MC . (2002). Proc. Natl. Acad. Sci. USA, 99, 4221–4226.

  • Taylor ML and Metcalfe DD . (2000). Hematol. Oncol. Clin. N Am., 14, 517–535.

  • Tusher VG, Tibshirani R and Chu G . (2001). Proc. Natl. Acad. Sci. USA, 98, 5116–5121.

  • Tuveson DA, Willis NA, Jacks T, Griffin JD, Singer S, Fletcher CD, Fletcher JA and Demetri GD . (2001). Oncogene, 20, 5054–5058.

  • Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J and Evans GA . (1998). Science, 282, 284–287.

  • West RB, Corless CL, Rubin BP, Chen X, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Browm PO, Heinrich MC and van de Rijn M . (2004). Am. J. Pathol., 165, 107–113.

  • Yu Y, Khan J, Khanna C, Helman L, Meltzer PS and Merlino G . (2004). Nat. Med., 10, 175–181.

Download references

Acknowledgements

SS was supported by a fellowship from the Laboratory of Surgical Pathology, Department of Pathology, Stanford University Medical Center. This work was supported by NIH Grant CA85129.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matt van de Rijn.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Subramanian, S., West, R., Corless, C. et al. Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles. Oncogene 23, 7780–7790 (2004). https://doi.org/10.1038/sj.onc.1208056

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208056

Keywords

This article is cited by

Search

Quick links